K161521 is an FDA 510(k) clearance for the TAP Blood Collection Device. This device is classified as a Capillary Blood Collection Device For Alternative Site Collection (Class II - Special Controls, product code PRJ).
Submitted by Seventh Sense Biosystems, Inc. (Medford, US). The FDA issued a Cleared decision on February 16, 2017, 259 days after receiving the submission on June 2, 2016.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1675. A Capillary Blood Collection Device With Or Without Integrated Micro-needles Is A Blood Collection Device Intended To Collect And/or Transport Capillary Whole Blood Specimens For Testing Of Clinical Analytes..